Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FBSciences is an agricultural biologicals company focused on naturally derived plant, soil, and climate health solutions rather than human therapeutics. The company develops and commercializes biostimulants, biopesticides, and crop nutrition technologies for agriculture and horticulture, with flagship platforms including FBS Transit and FBS Defense. Founded in 2007 in Tennessee, FBSciences built a science-driven portfolio around proprietary naturally derived active ingredients and broad crop applications. In January 2023, the company was acquired by Valent BioSciences, part of Sumitomo Chemical, to expand the combined group’s position in biorationals and biostimulants. FBSciences appears to continue operating as an active brand/company identity within the agricultural biologicals ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FBSciences.